We did not find any significant correlation between a specific histomorphological subtype and FGFR2 amplification in upper GIT adenocarcinoma; in particular, we found an equal proportion of diffuse and intestinal morphology in FGFR2-amplified gastric carcinomas. The gene discussed is FGFR2; the disease is gastric carcinoma.